): Mai Huong Nguyen, M.D. began her position at UCLA in July 1995 as Assistant Professor of Surgery in the Division of Oncology. Previously, she was trained as a surgical oncologist and did research in tumor angiogenesis at Harvard Medical School. Her goal is to become an independent physician scientist and teacher. She is dedicated to cancer research. UCLA is an established institution with many resources, and the Division of Surgical Oncology is committed towards her development as a physician scientist. The survival and growth of solid tumors is dependent on their ability to initiate and sustain new capillary growth, i.e., angiogenesis. The overall goal of Dr. Nguyen's research is to establish the importance of adhesion molecules important in tumor angiogenesis and metastasis. Specifically, her strategy is to analyze the role of E-selectin and its sialyl Lewis X/A glycoconjugates in tumor angiogenesis and metastasis.
Her first aim i ncludes: 1A) To determine whether E-selectin is preferentially expressed in the endothelium of the proliferating tumor capillaries by immunohistochemistry of human cancer specimens and by measuring the in vitro expression of E-selectin of endothelial cells within a tumor environment; 1B) To determine whether angiogenesis can be suppressed in vitro and in vivo by specific inhibitors which interfere with the interaction between E-selectin and sialyl Lewis X/A; and 1C) To construct an adenoviral plasmid linked to the E-selectin promoter in order to specifically target the tumor vasculature for future gene therapy.
Her second aim i ncludes: 2A) To determine whether metastasis can be suppressed in vivo by specific inhibitors which interfere with the interaction between E-selectin and sialyl Lewis X/A; and 2B) To identify and characterize the tumor cell glycoprotein which carries the sialyl Lewis X/A glycoconjugates. These studies will add to the understanding of the role of cell adhesion molecules in tumor angiogenesis and metastasis, and may result in a novel approach toward cancer therapeutics.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08CA069433-04
Application #
2895453
Study Section
Cancer Research Manpower and Education Review Committee (CRME)
Program Officer
Myrick, Dorkina C
Project Start
1996-09-30
Project End
2001-08-31
Budget Start
1999-09-01
Budget End
2000-08-31
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Surgery
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Liu, Canhui; Zhang, Liping; Shao, Zhi-Ming et al. (2002) Identification of a novel endothelial-derived gene EG-1. Biochem Biophys Res Commun 290:602-12
Liu, C; Shao, Z M; Zhang, L et al. (2001) Human endomucin is an endothelial marker. Biochem Biophys Res Commun 288:129-36
Tomlinson, J; Wang, J L; Barsky, S H et al. (2000) Human colon cancer cells express multiple glycoprotein ligands for E-selectin. Int J Oncol 16:347-53
Wang, J L; Liu, Y H; Lee, M C et al. (2000) Identification of tumor angiogenesis-related genes by subtractive hybridization. Microvasc Res 59:394-7
Tomlinson, J; Barsky, S H; Nelson, S et al. (1999) Different patterns of angiogenesis in sarcomas and carcinomas. Clin Cancer Res 5:3516-22
Walton, T; Wang, J L; Ribas, A et al. (1998) Endothelium-specific expression of an E-selectin promoter recombinant adenoviral vector. Anticancer Res 18:1357-60